documents: FDA-2022-D-0084-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-0084-0001 FDA FDA-2022-D-0084 Use of Circulating Tumor Deoxyribonucleic Acid for Early-Stage Solid Tumor Drug Development; Draft Guidance for Industry; Availability Notice Notice of Availability 2022-05-03T04:00:00Z 2022 5 2022-05-03T04:00:00Z   2022-07-06T01:00:44Z 2022-09459 0 0 0900006485049959

Links from other tables